Fluck M, Schaffhausen B
Microbiol Mol Biol Rev. 2009; 73(3):542-63, Table of Contents.
PMID: 19721090
PMC: 2738132.
DOI: 10.1128/MMBR.00009-09.
Schaffhausen B, Roberts T
Virology. 2008; 384(2):304-16.
PMID: 19022468
PMC: 2676342.
DOI: 10.1016/j.virol.2008.09.042.
Whalen K, Weber G, Benjamin T, Schaffhausen B
J Virol. 2008; 82(10):4946-54.
PMID: 18337582
PMC: 2346735.
DOI: 10.1128/JVI.02650-07.
Utermark T, Schaffhausen B, Roberts T, Zhao J
J Virol. 2007; 81(13):7069-76.
PMID: 17442716
PMC: 1933267.
DOI: 10.1128/JVI.00115-07.
Chen L, Wang X, Fluck M
J Virol. 2006; 80(15):7295-307.
PMID: 16840310
PMC: 1563708.
DOI: 10.1128/JVI.00679-06.
A new class of mutations reveals a novel function for the original phosphatidylinositol 3-kinase binding site.
Hong Y, Mikami A, Schaffhausen B, Jun T, Roberts T
Proc Natl Acad Sci U S A. 2003; 100(16):9434-9.
PMID: 12881485
PMC: 170936.
DOI: 10.1073/pnas.1432964100.
Natural biology of polyomavirus middle T antigen.
Gottlieb K, Villarreal L
Microbiol Mol Biol Rev. 2001; 65(2):288-318 ; second and third pages, table of contents.
PMID: 11381103
PMC: 99028.
DOI: 10.1128/MMBR.65.2.288-318.2001.
Signaling from polyomavirus middle T and small T defines different roles for protein phosphatase 2A.
Mullane K, Ratnofsky M, Cullere X, Schaffhausen B
Mol Cell Biol. 1998; 18(12):7556-64.
PMID: 9819441
PMC: 109336.
DOI: 10.1128/MCB.18.12.7556.
Transformation and tumorigenic properties of a mutant polyomavirus containing a middle T antigen defective in Shc binding.
Yi X, Peterson J, Freund R
J Virol. 1997; 71(9):6279-86.
PMID: 9261344
PMC: 191900.
DOI: 10.1128/JVI.71.9.6279-6286.1997.
Tumor induction by a transformation-defective polyoma virus mutant blocked in signaling through Shc.
Bronson R, Dawe C, Carroll J, Benjamin T
Proc Natl Acad Sci U S A. 1997; 94(15):7954-8.
PMID: 9223294
PMC: 21536.
DOI: 10.1073/pnas.94.15.7954.
Studies of partially transforming polyomavirus mutants establish a role for phosphatidylinositol 3-kinase in activation of pp70 S6 kinase.
Dahl J, Freund R, Blenis J, BENJAMIN T
Mol Cell Biol. 1996; 16(6):2728-35.
PMID: 8649380
PMC: 231263.
DOI: 10.1128/MCB.16.6.2728.
Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes.
Hu E, Mueller E, Oliviero S, Papaioannou V, Johnson R, Spiegelman B
EMBO J. 1994; 13(13):3094-103.
PMID: 8039503
PMC: 395200.
DOI: 10.1002/j.1460-2075.1994.tb06608.x.
Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen.
Campbell K, Ogris E, Burke B, Su W, Auger K, Druker B
Proc Natl Acad Sci U S A. 1994; 91(14):6344-8.
PMID: 8022784
PMC: 44198.
DOI: 10.1073/pnas.91.14.6344.
Polyomavirus middle-sized tumor antigen modulates c-Jun phosphorylation and transcriptional activity.
Srinivas S, Schonthal A, Eckhart W
Proc Natl Acad Sci U S A. 1994; 91(21):10064-8.
PMID: 7937838
PMC: 44958.
DOI: 10.1073/pnas.91.21.10064.
Mitosis-specific phosphorylation of polyomavirus middle-sized tumor antigen and its role during cell transformation.
Perez L, Paasinen A, Schnierle B, Kach S, Senften M, Ballmer-Hofer K
Proc Natl Acad Sci U S A. 1993; 90(17):8113-7.
PMID: 7690142
PMC: 47298.
DOI: 10.1073/pnas.90.17.8113.
Novel monoclonal antibodies that differentiate between the binding of pp60c-src or protein phosphatase 2A by polyomavirus middle T antigen.
Dilworth S, Horner V
J Virol. 1993; 67(4):2235-44.
PMID: 7680389
PMC: 240352.
DOI: 10.1128/JVI.67.4.2235-2244.1993.
Mutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation.
Glenn G, Eckhart W
J Virol. 1993; 67(4):1945-52.
PMID: 7680388
PMC: 240262.
DOI: 10.1128/JVI.67.4.1945-1952.1993.
Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav.
Songyang Z, Shoelson S, McGlade J, Olivier P, Pawson T, Bustelo X
Mol Cell Biol. 1994; 14(4):2777-85.
PMID: 7511210
PMC: 358643.
DOI: 10.1128/mcb.14.4.2777-2785.1994.
D-3-deoxy-3-substituted myo-inositol analogues as inhibitors of cell growth.
Powis G, Aksoy I, Melder D, Aksoy S, EICHINGER H, Fauq A
Cancer Chemother Pharmacol. 1991; 29(2):95-104.
PMID: 1760864
DOI: 10.1007/BF00687317.
Generation of a large library of point mutations in polyoma middle T antigen.
Druker B, Roberts T
Nucleic Acids Res. 1991; 19(24):6855-61.
PMID: 1662365
PMC: 329320.
DOI: 10.1093/nar/19.24.6855.